Dialysis centers in the United States were surveyed in 1994 regarding a number of hemodialysis associated diseases and practices.
A total of 2,449 centers, representing 206,884 patients and 50,314 staff members, responded.
In 1994,99% of centers used bicarbonate dialysate as the primary method of dialysis, 45% used high flux dialysis, and 75% reused dialyzers.
Hepatitis B vaccine had been administered to 31% of patients and to 80% of staff members.
Acute infection with hepatitis B virus occurred in 0.1% of patients and was more likely to be reported by centers with lower proportions of patients vaccinated against hepatitis B virus and those not using a separate room and dialysis machine to treat hepatitis B surface antigen positive patients.
The prevalence of antibody to hepatitis C virus was 10.5% among patients and 1.9% among staff members and varied according to geographic region.
Pyrogenic reactions in the absence of septicemia were reported by 22% of centers and were most highly associated with dialyzer reuse.
Human immunodeficiency virus infection was reported to be present in 1.5% of patients ; 37% of centers provided hemodialysis to one or more patients infected with human immunodeficiency virus.
Mots-clés Pascal : Hémodialyse, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Complication, Surveillance, Homme, Epuration extrarénale
Mots-clés Pascal anglais : Hemodialysis, Epidemiology, United States, North America, America, Complication, Surveillance, Human, Extrarenal dialysis
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0181360
Code Inist : 002B27B03. Création : 21/05/1997.